BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 1522363)

  • 1. Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions, and bacteriological loads: implications in the pathogenesis, epidemiology and serodiagnosis of leprosy and tuberculosis.
    David HL; Papa F; Cruaud P; Berlie HC; Maroja MF; Salem JI; Costa MF
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):208-24. PubMed ID: 1522363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological response to homologous and heterologous phenolic glycolipid antigens in tuberculosis and leprosy.
    Torgal-Garcia J; Papa F; David HL
    Acta Leprol; 1989; 7 Suppl 1():102-6. PubMed ID: 2503962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
    Vikerfors T; Olcén P; Wiker H; Watson JD
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological activity of natural disaccharide octyl bovine serum albumin (ND-O-BSA) in sera from patients with leprosy, tuberculosis, and normal controls.
    Wu QX; Ye GY; Li XY
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):50-5. PubMed ID: 3131466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
    Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
    Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
    Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH
    Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
    Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
    Brett SJ; Draper P; Payne SN; Rees RJ
    Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
    Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of phenolic glycolipid-I (Mycobacterium leprae) and sulfolipid-I (M. tuberculosis) by serum from Mexican patients with leprosy or tuberculosis.
    Rojas-Espinosa O; Luna-Herrera J; Arce-Paredes P
    Int J Tuberc Lung Dis; 1999 Dec; 3(12):1106-12. PubMed ID: 10599015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Armadillo IgG and IgM antibody responses to phenolic glycolipid-I during experimental infection with M. leprae.
    Vadiee AR; Shannon EJ; Gillis TP; Mshana RN; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):422-7. PubMed ID: 3047283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy.
    Agis F; Schlich P; Cartel JL; Guidi C; Bach MA
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):527-35. PubMed ID: 3065419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
    Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
    Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to the 18-kDa protein of Mycobacterium leprae in leprosy and tuberculosis patients.
    Roche PW; Prestidge RL; Watson JD; Britton WJ
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):201-7. PubMed ID: 1381739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts.
    Mathew JM; Muthukkaruppan V
    Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative study of the relationship between systemic and histological parameters of immunity in individual leprosy patients.
    Cree IA; Smith WC; Beck JS
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):347-52. PubMed ID: 2198317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.